Drug Formulary Review articles from September 2005

Drug Formulary Review archives from September 2005

Joint Commission issues alert on vincristine administration.
September 1, 2005... Joint Commission issues alert on vincristine administration 'Tragic errors' continue to occur, the organization says Saying "tragic errors" related to vincristine administration continue to occur, the Joint Commission on Accreditation...

New law legally protects adverse event information.
September 1, 2005... New law legally protects adverse event information Pharmacists should be encouraged to report medication adverse events (AEs) and their underlying causes under a new law signed by President Bush on July 29. The Patient Safety and...

Study: Number of adverse events involves med errors.
September 1, 2005... Study: Number of adverse events involves med errors Facility used CPOE system and on-site pharmacists A teaching hospital further improved its existing safety mechanisms after a study of critically ill patients found a significant...

Research News: Study: Customizing simple regimen raises adherence.
September 1, 2005... Study: Customizing simple regimen raises adherence Those with acute conditions stick to plan more often Hospital admissions related to poor medication adherence cost the United States billions of dollars a year. Two physicians recently...

News Briefs.
September 1, 2005... FDA wants Purdue Pharma to pull Palladone The FDA has asked Purdue Pharma LP to withdraw its pain management drug hydromorphone hydrochloride (Palladone) from the market. The agency made this request after acquiring new information about...

New FDA Approvals.
September 1, 2005... * New indication for celecoxib (Celebrex) by Pfizer. The FDA has approved the selective COX-2 inhibitor celecoxib (Celebrex) for a new indication, the relief of the signs and symptoms associated with ankylosing spondylitis. The FDA also...

Drug Criteria & Outcomes: Drug evaluation: Dexmethylphenidate hydrochloride tablets (Focalin).
September 1, 2005... Drug Criteria & Outcomes Drug evaluation: Dexmethylphenidate hydrochloride tablets (Focalin) Part 1: Mechanism of Action, Pharmacokinetics, Indication, Dosage, Contraindications, Drug Interactions, Adverse Reactions, Warnings and...

In The Pipeline.
September 1, 2005... *Genelabs Technologies has received orphan drug designation for prasterone (Prestara), its investigational drug for lupus. *Novartis has announced that its New Drug Application for deferasirox (Exjade) has been granted priority review by...

CE questions.
September 1, 2005... CE questions Pharmacists participate in this continuing education program by reading the article, using the provided references for further research, and studying the CE questions. Participants should select what they believe to be the...